• Hemophagocytic lymphohistiocytosis diagnosed by bone marrow trephine biopsy in living post-COVID-19 patients: case report and mini-review 

      Ioannou M., Zacharouli K., Doukas S.G., Diamantidis M.D., Tsangari V., Karakousis K., Koukoulis G.K., Vageli D.P. (2022)
      Hemophagocytic lymphohistiocytosis (HLH) constitutes a life-threatening inflammatory syndrome. Postmortem histological findings of bone marrow (BM) from COVID-19 patients showed histiocytosis and hemophagocytosis and ...
    • Thrombolysis in stroke patients with elevated inflammatory markers 

      Altersberger V.L., Enz L.S., Sibolt G., Hametner C., Nannoni S., Heldner M.R., Stolp J., Jovanovic D.R., Zini A., Pezzini A., Wegener S., Cereda C.W., Ntaios G., Räty S., Gumbinger C., Heyse M., Polymeris A.A., Zietz A., Schaufelbuehl A., Strambo D., Padlina G., Slavova N., Tiainen M., Valkonen K., Velzen T.J., Bigliardi G., Stanarcevic P., Magoni M., Luft A., Bejot Y., Vandelli L., Padjen V., Nederkoorn P.J., Arnold M., Michel P., Ringleb P.A., Curtze S., Engelter S.T., Gensicke H., for the Thrombolysis in Stroke Patients (TRISP) collaborators (2022)
      Objective: To investigate the prognostic value of white blood cell count (WBC) on functional outcome, mortality and bleeding risk in stroke patients treated with intravenous thrombolysis (IVT). Methods: In this prospective ...